WebDiscussion. In a previous study, we showed that DM was the high-risk factor for cisplatin-induced AKI. 5 However, no attempt was made to identify the mechanism for the development of AKI in patients with DM. MATE1/SLC47A1, an organic cation transporter in proximal tubular epithelial cells, mediates the tubular secretion of cationic drugs or … WebIn contrast to other drugs of the platinum-based antineoplastic class of drugs cisplatin and carboplatin, oxaliplatin features the bidentate ligand trans -1,2-diaminocyclohexane in place of the two monodentate ammine ligands. It also features a bidentate oxalate group. [5]
Bladder Cancer Treatment Regimens - Cancer Therapy Advisor
WebWe investigated the activity and safety of first-line GEMOX compared with gemcitabine–carboplatin (GCb) in cisplatin-ineligible patients with advanced UCC. Methods: Treatment-naive, cisplatin-ineligible patients with advanced UCC were randomly assigned to GEMOX (gemcitabine 1000 mg/m 2 , oxaliplatin 100 mg/m 2 on day 1 [D1] … WebJun 27, 2024 · Oncologists stay up-to-date on cisplatin, oxaliplatin and 5-FU. Visit often for the latest information. ... Paclitaxel + Carboplatin (Category 2B) 17.18,h. Day 1: Paclitaxel 50mg/m 2 IV over 1 ... inc tops for women
The side effects of platinum-based chemotherapy drugs: …
WebMar 27, 2024 · (1) Background: Malignant pleural mesothelioma (MPM) is a rare but aggressive tumor arising from the pleural surface. For relapsed MPM, there is no accepted standard of- are for subsequent treatment. Thus, we aimed to compare the efficacy of chemotherapy, targeting drugs, and immune-checkpoint inhibitors (ICIs) as subsequent … WebCarboplatin (Paraplatin) Irritant Cold - Every 8 hours for 3 days; if using sodium thiosulfate, apply cold pack for 6 to 12 hours after administration of sodium thiosulfate ... Cisplatin (Platinol) Vesicant (in concentrations ≥0.5 mg/mL) Irritant (in concentrations less than 0.5 mg/mL) ... Oxaliplatin (Eloxatin) Irritant (usually) Vesicant ... WebMay 25, 2024 · 9061 Background: Current standard of care first line treatment for extensive stage SCLC includes combination of platinum-etoposide doublet with an immune checkpoint inhibitor. Carboplatin is preferred over cisplatin in the extensive stage disease because of its favorable toxicity profile. Data comparing the efficacy of carboplatin with cisplatin in … include kiribati